Background: No fully validated index is available for assessing overall disease activity in systemic sclerosis (SSc).
Objectives: To estimate the effect of disease activity as measured by different disease activity indices on the risk of subsequent organ damage.
Methods: The European Systemic sclerosis study group activity index (EScSG AI), the European Scleroderma Trials and Research Group Activity Index (r-EUSTAR AI), 12 point activity index proposed by Minier (12point AI) were calculated for 91 patients; the CRISS (The Composite Response Index for Systemic Sclerosis) for patients included after 2016.